Phyo Than Htoo

12PUBLICATIONS
20CO-AUTHORS
Epidemiological methodsPharmacogenomicsEconomic models and forecastingEpidemiological modellingStochastic analysis and modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 24, 2026
Post hoc Population Standardization of Trial Emulation Studies in Claims Data: An RCT-DUPLICATE Analysis.

Phyo Than Htoo, Elisabetta Patorno, Sebastian Schneeweiss

|Nov 03, 2025
Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes.

Salvatore Crisafulli, Wajd Alkabbani, Julie M Paik

|Oct 15, 2025
Comparative healthcare resource utilization and costs of empagliflozin and GLP-1 receptor agonists in type 2 diabetes.

Phyo Than Htoo, Helen Tesfaye, Sebastian Schneeweiss

|Jun 25, 2024
Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes.

Phyo Than Htoo, Mehdi NajafZadeh, Helen Tesfaye

|Mar 21, 2024
Effectiveness and safety of empagliflozin: final results from the EMPRISE study.

Phyo T Htoo, Helen Tesfaye, Sebastian Schneeweiss

Pageof 2